Advertisement
Screener

CannAwake Corp Spending and interest coverage

CannAwake Corp Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2018-09-30..
  • Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2018-09-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2018-09-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2018-09-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months(m)Share-based compensation / revenue. Period ending 2018-09-30.

Calculation unavailable: missing inputs remain (m).

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue(m)
Stock-based compensation(m)Share-based Payment Arrangement, Noncash Expense
Operating income-1.34M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2018-09-30(m)(m)(m)$-1.34M(m)(m)(m)(m)(m)
2018-06-30(m)(m)(m)$-1.12M(m)(m)(m)(m)(m)
2018-03-31(m)(m)(m)$-545.69K(m)(m)(m)(m)(m)
2017-12-31(m)(m)(m)$-566.99K(m)(m)(m)(m)(m)
2017-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-03-31(m)(m)(m)$-330.67K(m)(m)(m)(m)(m)
2016-12-31(m)(m)(m)$-333.11K(m)(m)(m)(m)(m)
2016-09-30(m)(m)(m)$-331.51K(m)(m)(m)(m)(m)
2016-06-30(m)(m)(m)$-384.65K(m)(m)(m)(m)(m)
2016-03-31(m)(m)(m)$-407.75K(m)(m)(m)(m)(m)
2015-12-31(m)(m)(m)$-495.50K(m)(m)(m)(m)(m)
2015-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-06-30(m)(m)(m)$-4.93M(m)(m)(m)(m)(m)
2015-03-31(m)(m)(m)$-5.02M(m)(m)(m)(m)(m)
2014-12-31(m)(m)(m)$-5.09M$7.41K(m)(m)-686.59×Reported
2014-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-03-31(m)(m)(m)$-876.99K$32.07K(m)(m)-27.35×Reported
2013-12-31(m)(m)(m)$-816.48K$41.43K(m)(m)-19.71×Reported
2013-09-30(m)(m)(m)$-915.13K$41.03K(m)(m)-22.30×Reported
2013-06-30(m)(m)(m)$-929.25K$50.39K(m)(m)-18.44×Reported
2013-03-31(m)(m)(m)$-1.06M$50.39K(m)(m)-21.06×Reported
2012-12-31(m)$1.58K(m)$-1.36M$50.11K(m)(m)-27.17×Reported
2012-09-30(m)(m)(m)$-1.36M$49.83K(m)(m)-27.33×Reported
2012-06-30(m)(m)(m)$-1.29M$48.24K(m)(m)-26.71×Reported
2012-03-31(m)(m)(m)$-1.13M$46.66K(m)(m)-24.31×Reported
2011-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-12-31(m)(m)(m)$-824.57K$43.47K(m)(m)-18.97×Reported
2010-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.